department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Efavirenz · pharmadog

pharmadog
drugs
Efavirenz

drug

patient view →

efavirenz

Marketedupdated 2mo ago

by Camber Pharmaceuticals Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Efavirenz

generic

efavirenz

indication

Human Immunodeficiency Virus (HIV) Infections (AIDS)

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 28, 2029

~2.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (3)

Apr 28, 2029formulationUS 85981852.8y
Jun 13, 2026method-of-use (U-1170)US 9018192
Jun 13, 2026formulationUS 9545414

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying efavirenz

phase1Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participantsactive not recruitingn=18
phase3Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)completedn=195
phase1A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participantsnot yet recruitingn=80
phase1A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)completedn=34
phase1Drug-Drug Interaction Potential of Mavorixaforcompletedn=38
phase1An Open-label DDI Study of Omaveloxolone in Healthy Subjectscompletedn=20
phase1A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)completedn=16
phase1TGRX-326 Pharmacokinetic Drug Interactioncompletedn=34

more trials →